Accuray applies for Tomo C Chinese market clearance

2019 09 17 16 01 9179 Accuray Astro 2019

Radiation therapy developer Accuray has applied to the Chinese National Medical Products Administration for market clearance for its Tomo C radiation therapy system.

The application was filed under the auspices of the CNNC-Accuray joint venture, which was established in 2019 and is based in Tianjin, China, the company said.

Tomo C offers integrated helical fan-beam imaging and radiation delivery in conventionally fractionated or ultrahypofractionated treatments, according to the firm.

Page 1 of 562
Next Page